Moderna’s Shift to Cancer Company Lifts Stock Up 177%

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else. Drugs (Pharmaceuticals), Vaccination and Immunization, Coronavirus (2019-nCoV), Trump, Donald J, Bancel, Stephane, Kennedy, Robert F Jr, Health and Human Services Department, Moderna Inc, Merck & Company Inc Read More

Leave a Comment

Your email address will not be published. Required fields are marked *